Machine learning applied in patient-reported outcome research—exploring symptoms in adjuvant treatment of breast cancer-Reference-Cited by-同舟云学术

Machine learning applied in patient-reported outcome research—exploring symptoms in adjuvant treatment of breast cancer

Published:2023-11-08 Issue:1 Volume:31 Page:148-153
ISSN:1340-6868
Container-title:Breast Cancer
language:en
Short-container-title:Breast Cancer

Author:

Pappot Helle^ORCID,Björnsson Benóný P.,Krause Oswin,Bæksted Christina,Bidstrup Pernille E.,Dalton Susanne O.,Johansen Christoffer,Knoop Ann,Vogelius Ivan,Holländer-Mieritz Cecilie

Funder

Pfizer

Kræftens Bekæmpelse

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12282-023-01515-9.pdf

Reference21 articles.

1. Kotronoulas G, Kearney N, Maguire R, et al. What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol. 2014;32(14):1480–501.

2. Basch E, Deal AM, Dueck AC, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017;318(2):197–8.

3. Denis F, Basch E, Septans AL, et al. Two-year survival comparing web-based symptom monitoring vs routine surveillance following treatment for lung cancer. JAMA. 2019;321(3):306–7.

4. Barbera L, Sutradhar R, Seow H, et al. The impact of routine edmonton symptom assessment system (ESAS) use on overall survival in cancer patients: results of a population-based retrospective matched cohort analysis. Cancer Med. 2020;9(19):7107–15.

5. Basch E, Charlot M, Dueck AC. Population-level evidence of survival benefits of patient-reported outcome symptom monitoring software systems in routine cancer care. Cancer Med. 2020;9(21):7797–9.